Bank of Nova Scotia »

An2 Therapeutics shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2025-09-30 $583k 459k 1.27
2025-06-30 $487k 459k 1.06
2025-03-31 $625k 459k 1.36
2024-12-31 $545k 395k 1.38

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Apple (AAPL)
Key (KEY)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Cibc Cad (CM)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Meta Platforms Cl A (META)

View all positions for Bank of Nova Scotia

Top funds holding An2 Therapeutics

Almitas Capital
Vanguard Group
Pfizer
Peapod Lane Capital
Stonepine Capital Management
Bank of Nova Scotia
Landscape Capital Management
Bank Of Montreal
Renaissance Technologies
BlackRock
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Morgan Stanley
State Street Corporation

View all funds holding An2 Therapeutics